Items where authors include "Collis, S.J."

Article

Cheng, V.W.T., Vaughn-Beaucaire, P., Shaw, G.C. et al. (31 more authors) (2025) ARHGAP12 and ARHGAP29 exert distinct regulatory effects on switching between two cell morphological states through GSK-3 activity. Cell Reports, 44 (3). 115361. ISSN 2639-1856

Dada, O.E. orcid.org/0000-0001-8920-9449, Chisango, Z., Nkansah-Poku, K.A.B. et al. (10 more authors) (2025) Race and ‘omic’ data in glioma: a systematic review of contemporary research to explore the digital divide. Neuro-Oncology Practice. ISSN 2054-2577

Zhao, A. orcid.org/0000-0002-4626-9377, Maple, L. orcid.org/0000-0002-1068-2143, Jiang, J. et al. (12 more authors) (2024) SENP3-FIS1 axis promotes mitophagy and cell survival under hypoxia. Cell Death & Disease, 15 (12). 881. ISSN 2041-4889

Rominiyi, O. orcid.org/0000-0002-9724-0224, McGarrity-Cottrell, C., Myers, K.N. orcid.org/0000-0002-1951-4744 et al. (16 more authors) (2024) Ex-vivo models of post-surgical residual disease in human glioblastoma [version 1; peer review: awaiting peer review]. F1000Research, 13. 1316. ISSN 2046-1402

Derby, S., Dutton, L., Strathdee, K.E. et al. (27 more authors) (2024) Inhibition of ATR opposes glioblastoma invasion through disruption of cytoskeletal networks and integrin internalisation via macropinocytosis. Neuro-Oncology, 26 (4). pp. 625-639. ISSN 1522-8517

Jones, C.G. orcid.org/0000-0003-2958-8322, Vanderlinden, A., Rominiyi, O. orcid.org/0000-0002-9724-0224 et al. (1 more author) (2024) Development and optimisation of Tumour Treating Fields (TTFields) delivery within 3D primary glioma stem cell-like models of spatial heterogeneity. Cancers, 16 (5). 863. ISSN 2072-6694

Vanderlinden, A., Jones, C.G. orcid.org/0000-0003-2958-8322, Myers, K.N. et al. (2 more authors) (2023) DNA damage response inhibitors enhance tumour treating fields (TTFields) potency in glioma stem-like cells. British Journal of Cancer, 129. 1840. ISSN 0007-0920

Gagg, H. orcid.org/0000-0003-2763-0304, Williams, S.T., Conroy, S. et al. (9 more authors) (2023) Ex-vivo drug screening of surgically resected glioma stem cells to replace murine avatars and provide personalise cancer therapy for glioblastoma patients. F1000Research, 12. 954. ISSN 2046-1402

Patel, P., Alghamdi, A., Shaw, G. et al. (18 more authors) (2023) Development of a personalised device for systemic magnetic drug targeting to brain tumours. Nanotheranostics, 7 (1). pp. 102-116. ISSN 2206-7418

Rominiyi, O. orcid.org/0000-0002-9724-0224 and Collis, S.J. orcid.org/0000-0002-7874-1891 (2022) DDRugging glioblastoma: understanding and targeting the DNA damage response to improve future therapies. Molecular Oncology, 16 (1). pp. 11-41. ISSN 1574-7891

Williams, S.T., Wells, G. orcid.org/0000-0002-1337-9836, Conroy, S. et al. (9 more authors) (2022) Precision oncology using ex vivo technology: a step towards individualised cancer care? Expert Reviews in Molecular Medicine, 24. e39. ISSN 1462-3994

Carmell, N., Rominiyi, O. orcid.org/0000-0002-9724-0224, Myers, K.N. et al. (9 more authors) (2021) Identification and validation of ERK5 as a DNA damage modulating drug target in glioblastoma. Cancers, 13 (5). 944. ISSN 2072-6694

Rominiyi, O., Vanderlinden, A., Clenton, S.J. et al. (3 more authors) (2021) Tumour treating fields therapy for glioblastoma : current advances and future directions. British Journal of Cancer, 124. pp. 697-709. ISSN 0007-0920

Bennett, L.G., Wilkie, A.M., Antonopoulou, E. et al. (8 more authors) (2020) MRNIP is a replication fork protection factor. Science Advances, 6 (28). eaba5974. ISSN 2375-2548

O'Regan, L., Barone, G., Adib, R. et al. (10 more authors) (2020) EML4-ALK V3 oncogenic fusion proteins promote microtubule stabilization and accelerated migration through NEK9 and NEK7. Journal of Cell Science, 133 (9). jcs.241505. ISSN 0021-9533

Rominiyi, O. orcid.org/0000-0002-9724-0224, Al-Tamimi, Y. orcid.org/0000-0002-9014-2728 and Collis, S.J. orcid.org/0000-0002-7874-1891 (2019) The 'Ins and Outs' of Early Preclinical Models for Brain Tumor Research: Are They Valuable and Have We Been Doing It Wrong? Cancers, 11 (3). 426. ISSN 2072-6694

Barone, G., Arora, A., Ganesh, A. et al. (11 more authors) (2018) The relationship of CDK18 expression in breast cancer to clinicopathological parameters and therapeutic response. Oncotarget, 9 (50). pp. 29508-29524.

Myers, K.N., Barone, G., Ganesh, A. et al. (6 more authors) (2016) The bornavirus-derived human protein EBLN1 promotes efficient cell cycle transit, microtubule organisation and genome stability. Scientific Reports, 6. p. 35548. ISSN 2045-2322

Staples, C.J., Barone, G., Myers, K.N. et al. (10 more authors) (2016) MRNIP/C5orf45 Interacts with the MRN Complex and Contributes to the DNA Damage Response. Cell Reports, 16. pp. 1-11. ISSN 2211-1247

Barone, G., Staples, C.J., Ganesh, A. et al. (9 more authors) (2016) Human CDK18 promotes replication stress signaling and genome stability. Nucleic Acids Research. ISSN 0305-1048

Johnson, C.A. and Collis, S.J. orcid.org/0000-0002-7874-1891 (2016) Ciliogenesis and the DNA damage response: A stressful relationship. Cilia, 5 (19). ISSN 2046-2530

Patil, A.A., Sayal, P., Depondt, M.L. et al. (9 more authors) (2014) FANCD2 re-expression is associated with glioma grade and chemical inhibition of the Fanconi Anaemia pathway sensitises gliomas to chemotherapeutic agents. Oncotarget, 5 (15). pp. 6414-6424. ISSN 1949-2553

Kachhap, S.K., Rosmus, N., Collis, S.J. orcid.org/0000-0002-7874-1891 et al. (13 more authors) (2010) Downregulation of Homologous Recombination DNA Repair Genes by HDAC Inhibition in Prostate Cancer Is Mediated through the E2F1 Transcription Factor. PLOS One, 5 (6). e11208. ISSN 1932-6203

Proceedings Paper

Marples, B., Krueger, S.A., Wilson, T.G. et al. (5 more authors) (2016) Improving the Efficacy of Pulsed Radiation Therapy Using DNA Repair Inhibitors: A Preclinical Study. In: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. ASTRO 2016, September 25 - 28, 2016, Boston, Massachusetts, USA. Elsevier , E566-E567.